A detailed history of Key F Inancial Inc transactions in Abb Vie Inc. stock. As of the latest transaction made, Key F Inancial Inc holds 15,269 shares of ABBV stock, worth $3.01 Million. This represents 0.64% of its overall portfolio holdings.

Number of Shares
15,269
Previous 15,115 1.02%
Holding current value
$3.01 Million
Previous $2.75 Million 4.87%
% of portfolio
0.64%
Previous 0.71%

Shares

17 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Jul 29, 2024

BUY
$154.79 - $180.76 $23,837 - $27,837
154 Added 1.02%
15,269 $2.62 Million
Q1 2024

May 13, 2024

BUY
$159.82 - $182.1 $51,781 - $59,000
324 Added 2.19%
15,115 $2.75 Million
Q4 2023

Jan 31, 2024

BUY
$137.6 - $154.97 $2,064 - $2,324
15 Added 0.1%
14,791 $2.29 Million
Q3 2023

Nov 01, 2023

BUY
$133.59 - $154.65 $1,736 - $2,010
13 Added 0.09%
14,776 $2.2 Million
Q2 2023

Jul 28, 2023

BUY
$132.51 - $164.9 $84,541 - $105,206
638 Added 4.52%
14,763 $1.99 Million
Q1 2023

May 02, 2023

BUY
$144.61 - $166.54 $317,274 - $365,388
2,194 Added 18.39%
14,125 $2.25 Million
Q3 2022

Oct 28, 2022

BUY
$134.21 - $153.93 $731,041 - $838,456
5,447 Added 84.01%
11,931 $1.6 Million
Q2 2022

Jul 26, 2022

BUY
$137.62 - $174.96 $10,459 - $13,296
76 Added 1.19%
6,484 $997,000
Q1 2022

Apr 27, 2022

BUY
$131.98 - $163.75 $55,563 - $68,938
421 Added 7.03%
6,408 $1.04 Million
Q4 2021

Jan 19, 2022

BUY
$107.43 - $135.93 $1,181 - $1,495
11 Added 0.18%
5,987 $811,000
Q2 2021

Aug 02, 2021

BUY
$105.21 - $117.21 $11,678 - $13,010
111 Added 1.89%
5,976 $695,000
Q1 2021

Apr 30, 2021

BUY
$102.3 - $112.62 $16,368 - $18,019
160 Added 2.8%
5,865 $635,000
Q4 2020

Jan 29, 2021

SELL
$80.49 - $108.67 $8,048 - $10,867
-100 Reduced 1.72%
5,705 $611,000
Q3 2020

Nov 02, 2020

BUY
$85.91 - $100.83 $8,591 - $10,083
100 Added 1.75%
5,805 $508,000
Q2 2020

Aug 07, 2020

BUY
$73.37 - $98.18 $18,782 - $25,134
256 Added 4.7%
5,705 $550,000
Q1 2020

May 05, 2020

SELL
$64.5 - $97.79 $29,025 - $44,005
-450 Reduced 7.63%
5,449 $410,000
Q4 2019

Feb 11, 2020

BUY
$72.13 - $90.25 $425,494 - $532,384
5,899 New
5,899 $522,000

Others Institutions Holding ABBV

About AbbVie Inc.


  • Ticker ABBV
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 1,768,099,968
  • Market Cap $348B
  • Description
  • AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...
More about ABBV
Track This Portfolio

Track Key F Inancial Inc Portfolio

Follow Key F Inancial Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Key F Inancial Inc, based on Form 13F filings with the SEC.

News

Stay updated on Key F Inancial Inc with notifications on news.